NAD(P)H oxidase-derived reactive oxygen species regulate angiotensin-II induced adventitial fibroblast phenotypic differentiation

Shanghai Jiao Tong University, Shanghai, Shanghai Shi, China
Biochemical and Biophysical Research Communications (Impact Factor: 2.28). 02/2006; 339(1):337-43. DOI: 10.1016/j.bbrc.2005.10.207
Source: PubMed

ABSTRACT Phenotypic differentiation of adventitial fibroblasts into myofibroblasts is an essential feature of vascular remodeling. The present study was undertaken to test the hypothesis that reactive oxygen species (ROS) are involved in rat adventitial fibroblast differentiation to myofibroblast. Activation of alpha-smooth muscle actin (alpha-SMA) was used as a marker of myofibroblast. Angiotensin II increased intracellular ROS in adventitial fibroblasts that was completely inhibited by the free radical scavenger NAC, the NAD(P)H oxidase inhibitor DPI, and transfection of antisense gp91phox oligonucleotides. Myofibroblast differentiation was prevented by inhibition of ROS generation with DPI, NAC, and antisense gp91phox as shown by decreased expression of alpha-SMA. Angiotensin II rapidly induced phosphorylation of p38 MAPK and JNK, both of which were inhibited by DPI, NAC, antisense gp91phox, and the selective AT1 receptor antagonist, losartan. Inhibiting p38MAPK with SB202190 or JNK with SP600125 also reduced angiotensin II-induced alpha-SMA expression. These findings demonstrate that angiotensin II induces adventitial fibroblast differentiation to myofibroblast via a pathway that involves NADPH oxidase generation of ROS and activation of p38MAPK and JNK pathways.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Recent studies suggest that hyperhomocysteinemia (HHcy) increases collagen type I accumulation in rat vascular adventitia after balloon injury and that Angiotensin II (Ang II) induces collagen synthesis in vascular adventitial fibroblasts. Reports also indicate that Ang II type1 receptor (AT1R) activation, mediated by homocysteine (Hcy) may contribute to collagen type 1 expression in mouse aortic endothelial cells. However, little is known about the possible mechanisms behind the relationship between Hcy and AT1R in adventitial remodeling. Thus, we investigated whether HHcy induces collagen accumulation via activation of AT1R in the adventitia. Male Sprague-Dawley (SD) rats were randomly divided into a control group and a 1% l-methionine-induced HHcy group. Balloon injury was performed after 12 experimental weeks and animals were sacrificed at 7, 14, and 28 days after injury. Collagen deposition and AT1R expression was measured with Western blot. Serum Hcy, adventitial collagen, and AT1R levels were higher in the HHcy group compared with the control group. Hcy time-dependently induced collagen type 1 and AT1R expression, with the highest induction observed at 48 h. Also, we observed that the AT1R blocker, valsartan, attenuated collagen type 1 and AT1R expression. HHcy exacerbates adventitial remodeling after balloon injury, and the underling mechanisms may be related to AT1R activity.
    International Journal of Molecular Sciences 11/2014; 15(11):19487-98. DOI:10.3390/ijms151119487 · 2.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The small G-Proteins Rac1 and RhoA regulate actin cytoskeleton, cell shape, adhesion, migration, and proliferation. Recent studies in our laboratory showed that Nox4 NAD(P)H oxidase-derived reactive oxygen species (ROS) are involved in transforming growth factor-beta 1 (TGF-β1)-induced rat kidney myofibroblast differentiation assessed by the acquisition of an alpha-smooth muscle actin (α-SMA) phenotype and expression of an alternatively spliced fibronectin variant (Fn-EIIIA). Rac1 and RhoA are essential in signaling by some Nox homologs, but their role as effectors of Nox4 in kidney myofibroblast differentiation is not known. In the present study, we explored a link between Rac1 and RhoA and Nox4-dependent ROS generation in TGFβ1-induced kidney myofibroblast activation. TGF-β1 stimulated an increase in Nox4 protein expression, NADPH oxidase activity, and abundant α-SMA and Fn-EIIIA expression. RhoA, but not Rac1 was involved in TGF-β1-induction of Nox4 signaling of kidney myofibroblast activation. TGF-β1 stimulated active RhoA-GTP and increased Rho kinase (ROCK). Inhibition of RhoA with small interfering (si)RNA and ROCK using Y-27632 compound significantly reduced TGF-β1-induced stimulation of Nox4 protein, NADPH oxidase activity, α-SMA and Fn-EIIIA expression. Treatment with DPI, an inhibitor of NAD(P)H oxidase, did not decrease RhoA activation, but inhibited TGF-β1-induced α-SMA, Fn-EIIIA expression, indicating that RhoA is upstream of ROS generation. RhoA/ROCK also regulated polymerase [DNA-directed] delta-interacting protein 2 (Poldip2), a newly discovered Nox4 enhancer protein. Collectively, these data indicate that RhoA/ROCK is upstream of Poldip2-dependent Nox4 regulation and ROS production and induces redox signaling of kidney myofibroblast activation and may broader implications in the pathophysiology of renal fibrosis.
    American journal of physiology. Renal physiology 05/2014; 307(2). DOI:10.1152/ajprenal.00546.2013 · 3.30 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Atherosclerosis, the main pathophysiological condition leading to cardiovascular disease (CVD), is now considered to be a chronic inflammatory condition. Statins are the most widely used and promising agents in CVD and are renowned for their pleiotropic lipid lowering independent effects. Statins exert their anti-inflammatory effects on the vascular wall through their implication on a variety of molecular pathways of the innate and adaptive immune system, their impact on the circulating levels of proinflammatory cytokines and their effect on the adhesion molecules. By inhibiting the mevalonate pathway and isoprenoid formation, statins account for the increase of nitric oxide bioavailability and the improvement of vascular and myocardial redox state, by multiple different mechanisms (direct or indirect through LDL lowering). A large number of randomized control trials have well shown that statins help in the primary and secondary prevention of cardiovascular events not only via their lipid lowering effect by due to their anti-inflammatory potential as well. In this article we examine the molecular pathways in which statins are implicated and exert their anti-inflammatory effects, and we are focused specifically in their impact on innate and adaptive immunity. Finally we review the most important clinical data on the role of statins in primary and secondary prevention of cardiovascular events.
    Journal of the American College of Cardiology 06/2014; 63(23). DOI:10.1016/j.jacc.2014.01.054 · 15.34 Impact Factor